drugset
drugset / Trial / NCT06602284

A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

NCT06602284 ↗

Phase 2/3 Not yet recruiting 10 enrolled Equipmed USA LLC
NaSingle-groupOpen-labelTreatment

Summary

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Timeline

Start
2024-10
Primary completion
2025-03
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MG-CLR Unknown — —

Indications

acne